Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.34
Delayed Data
As of 3:59pm ET
 +0.02 / +0.86%
Today’s Change
0.49
Today|||52-Week Range
3.68
+138.82%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.32
Today’s open2.32
Day’s range2.21 - 2.40
Volume428,474
Average volume (3 months)603,832
Market cap$80.4M
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+34.87%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book25.01

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc0.000.00%
VRMLVermillion Inc+0.02+1.12%
TRIBTrinity Biotech PLC+0.15+2.84%
TRILTrillium Therapeutic...-0.05-0.88%
Data as of 3:59pm ET, 05/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts